FDA authorizes Quest Diagnostics' proprietary monkeypox test

Quest Diagnostics, a leading provider of diagnostic information services, has announced that it has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the company's lab-developed molecular diagnostic test to aid in the diagnosis of infection with the Monkeypox virus. 

Related Keywords

United States ,Jayg Wohlgemuth , ,Centers For Disease ,Human Services ,Drug Administration ,York Department Of Health ,Department Of Health ,Lab Alert ,Quest Diagnostics ,Industry News ,Quest Diagnostic ,Senior Vice President ,Chief Medical Officer ,West African ,Quest Monkeypox ,San Juan Capistrano ,New York ,Disease Control ,Federal Food ,Cosmetic Act ,Fda Authorizes Quest Diagnostics Proprietary Monkeypox Test For Emergency Use ,Virus ,Pest ,Cr ,Fda ,Ua ,